Actinonin—as a peptide deformylase inhibitor—is also an effective APN/CD13 inhibitor which has antiproliferative impact on human promyelocytic leukemia, human myeloid leukemia, and signalized antitumor effect on murine leukemia [42, 43]. The gene discussed is ANPEP; the disease is acute promyelocytic leukemia.